Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Foropin versus Gonal-f in assisted reproductive technology
IRCT20101012004920N13Phase 3Completed
- Sponsor
- Humer Novin Daroo
- Start
- Apr 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of follitropin alfa in female infertility (2 arms), sponsored by Humer Novin Daroo. Primary endpoint: Number of metaphase II oocytes. Started Apr 2025; status: completed.
02
Drugs
follitropin alfa
03
Conditions
female infertility
Beyond the preview
Go deeper on IRCT20101012004920N13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20101012004920N13.